4.7 Article

Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease

期刊

ISCIENCE
卷 26, 期 7, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.isci.2023.107127

关键词

-

向作者/读者索取更多资源

Non-alcoholic fatty liver disease (NAFLD) is a common disease without specific drug therapy. A study combining observational and Mendelian randomization analyses found that certain metabolic factors, such as triglyceride-rich and high-density lipoprotein particles composition, and the ratio of polyunsaturated fatty acids to total fatty acids, are associated with NAFLD risk. These findings provide evidence for potential therapeutic targets and interventions for NAFLD prevention and treatment.
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent disease with no specific drug therapy. High-throughput metabolomics present an unprecedented opportunity to identify biomarkers and potentially causal risk factors for NAFLD. Here, we determined the impact of 21 circulating metabolites, 17 lipids, and 132 lipoprotein particle characteristics on NAFLD combining prospective observational and two-sample Mendelian randomization (MR) analyses in 121,032 UK Biobank participants. We identified several metabolic factors associated with NAFLD risk in observational and MR analyses including triglyceride-rich and high-density lipoprotein particles composition, as well as the ratio of polyunsaturated fatty acids to total fatty acids. This study, is one of the largest to investigate incident NAFLD, provides concordant observational and genetic evidence that therapies aimed at reducing circulating triglycerides and increasing large HDL particles, as well as interventions aimed at increasing polyunsaturated fatty acid content may warrant further investigation into NAFLD prevention and treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据